Trulicity (dulaglutide) is a once-weekly injection for type 2 diabetes that holds approval for cardiovascular risk reduction
When appropriately tailored to the individual, these diets may complement semaglutide therapy by supporting treatment adherence, enhancing metabolic outcomes, and potentially mitigating GI AEs
Safety and eligibility questions to ask Online access does not replace clinical review
The national essential medicines list committee has prioritised the review of glucagon-like peptide (GLP)-1 medicines, according to a senior health department official
Discontinue use and consult a healthcare provider if you experience: Severe allergic reactions (rash, difficulty breathing, swelling), persistent injection site infections, or any concerning symptoms that do not resolve
Choose by skin need: Tip: You can find the full range of Mary&May products below, with filters by skin type and specific concern